Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae

Journal of Clinical Microbiology

Volumn 34, Issue 11, 1996, Pages 2679-2684

  Jorgensen, James H ^a   Swenson, Jana M ^b   Tenover, Fred C ^b   Barry, Arthur ^c   Ferraro, Mary Jane ^d   Murray, Patrick R ^e   Reller, L Barth ^f  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CLINICAL MICROBIOLOGY INSTITUTE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e WASHINGTON UNIVERSITY   (United States)

^f DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; DIRITHROMYCIN; ERYTHROMYCIN; MACROLIDE;

AGAR GEL DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CROSS RESISTANCE; DILUTION; MINIMUM INHIBITORY CONCENTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

EID: 0029956468     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.11.2679-2684.1996     Document Type: Article

References (19)

1. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliott, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
2. Chesney, P. J. 1992. The escalating problem of antimicrobial resistance in Streptococcus pneumoniae. Am. J. Dis. Child. 146:912-916.
3. Ednie, L. M., M. A. Visali, M. R. Jacobs, and P. C. Appelbaum. 1996. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob. Agents Chemother. 40:1950-1952.
4. Friedland, I. R., and G. H. McCracken, Jr. 1995. Management of infections caused by antibiotic resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
5. Gavan, T. L., R. N. Jones, A. L. Barry, P. C. Fuchs, E. H. Gerlach, J. M. Matsen, L. B. Reller, C. Thornsberry, and L. D. Thrupp. 1981. Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. J. Clin. Microbiol. 14:67-72.
6. Hofmann, J., M. S. Cetron, M. M. Farley, W. S. Baughman, R. R. Facklam, J. A. Elliott, K. A. Deaver, and R. F. Breiman. 1995. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N. Engl. J. Med. 333: 481-486.
7. Jacobs, M. R. 1992. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 15:119-127.
8. Jorgensen, J. H., J. M. Swenson, F. C. Tenover, M. J. Ferraro, J. A. Hindler, and P. R. Murray. 1994. Development of interpretive criteria and quality control limits tor broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae. J. Clin. Microbiol. 32:2448-2459.
9. Kirst, H. A., and G. D. Sides. 1989. New directions for macrolide antibiotics: structural modifications and in vitro activity. Antimicrob. Agents Chemother. 33:1413-1418.
10. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:171-196.
11. Metzler, C. M., and R. M. DeHaan. 1974. Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. J. Infect. Dis. 130:588-594.
12. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
13. National Committee for Clinical Laboratory Standards. 1993. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
14. National Committee for Clinical Laboratory Standards. 1994. Development of in vitro susceptibility testing criteria and quality control parameters. Tentative guideline M23-A. National Committee for Clinical Laboratory Standards, Villanova, Pa.
15. National Committee for Clinical Laboratory Standards. 1994. Performance standards for antimicrobial susceptibility testing. Fifth informational supplement M100-S5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. National Committee for Clinical Laboratory Standards. 1995. Performance standards for antimicrobial susceptibility testing. Sixth informational supplement M100-S6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
17. National Committee for Clinical Laboratory Standards. Data on file. National Committee for Clinical Laboratory Standards, Wayne, Pa.
18. Shortridge, D., R. K. Flamm, J. Beyer, V. C. Tenover, and S. K. Tanaka. 1996. Novel mechanism of macrolide resistance in Streptococcus pneumoniae, abstr. A-106, p. 152. In Abstracts of the 96th General Meeting of the American Society for Microbiology 1996. American Society for Microbiology, Washington, D.C.
19. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.